Tuomas Mirtti
Impact in
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 49
- Prostate Cancer Diagnosis and Treatment 26
- Co-authors
- Antti Rannikko (52 shared papers)Olli Kallioniemi (18 shared papers)Kalle Alanen (22 shared papers)Peter J. Boström (23 shared papers)Marja T. Nevalainen (14 shared papers)Kristiina Iljin (5 shared papers)Paula Vainio (5 shared papers)Johan Lundin (7 shared papers)
- Journals
- Cancer Research (8 papers)International Journal of Cancer (7 papers)Scientific Reports (6 papers)The Prostate (6 papers)PLoS ONE (6 papers)
- Partner nations
- FinlandUnited StatesSweden
In The Last Decade
Tuomas Mirtti
116 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 718
- Pulmonary and Respiratory Medicine 1.1k
- Oncology 825
- Molecular Biology 1.6k
- Urology 107
Countries citing papers authored by Tuomas Mirtti
This map shows the geographic impact of Tuomas Mirtti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomas Mirtti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomas Mirtti more than expected).
Fields of papers citing papers by Tuomas Mirtti
This network shows the impact of papers produced by Tuomas Mirtti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomas Mirtti. The network helps show where Tuomas Mirtti may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuomas Mirtti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 127 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 296 | |
| 2 | 2010 | 217 | |
| 3 | 2008 | 198 | |
| 4 | 2017 | 177 | |
| 5 | 2007 | 105 | |
| 6 | 2010 | 99 | |
| 7 | 2011 | 94 | |
| 8 | 2011 | 92 | |
| 9 | 2012 | 86 | |
| 10 | 2011 | 76 | |
| 11 | 2018 | 74 | |
| 12 | 2015 | 73 | |
| 13 | 2016 | 72 | |
| 14 | 2008 | 56 | |
| 15 | 2012 | 55 | |
| 16 | 2015 | 54 | |
| 17 | 2011 | 41 | |
| 18 | 2018 | 40 | |
| 19 | 2012 | 38 | |
| 20 | 2017 | 37 |
About Tuomas Mirtti
Tuomas Mirtti is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Surgery and Cancer Research, having authored 127 papers that have together received 3.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (49 papers), Prostate Cancer Diagnosis and Treatment (26 papers), Bladder and Urothelial Cancer Treatments (24 papers), Urinary and Genital Oncology Studies (13 papers), Radiomics and Machine Learning in Medical Imaging (13 papers), Cytokine Signaling Pathways and Interactions (11 papers), Cancer, Lipids, and Metabolism (8 papers) and AI in cancer detection (8 papers). The work is most often cited by research in Cancer Research (718 citations), Pulmonary and Respiratory Medicine (1.1k citations), Oncology (825 citations), Molecular Biology (1.6k citations) and Urology (107 citations). Tuomas Mirtti has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Antti Rannikko, Olli Kallioniemi, Kalle Alanen, Peter J. Boström, Marja T. Nevalainen, Kristiina Iljin, Paula Vainio, Johan Lundin, Matthias Nees and Stig Nordling. Their work appears in journals such as Cancer Research, International Journal of Cancer, Scientific Reports, The Prostate and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.